ImageneBio IMA
NASDAQ IMA
$3.72 -0.09 (-2.36%)
As of: Nov 11, 2026 · 3:56 PM EST

ImageneBio (IMA) Net Long-Term Debt Issued (Repaid) (2024)

Updated

ImageneBio (IMA) reported Non-Current Debt of $1.06 million for Q4 2024, up 11.7% from $950,000 a year earlier.

Analysis

ImageneBio (IMA) Net Long-Term Debt Issued (Repaid) (2024) Analysis & Trends

  • By year, Non-Current Debt came in at $950,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 ImageneBio 65.24 Mn -450.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 7.50 Mn
API Access

ImageneBio Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=IMA&period=max&api_key=YOUR_API_KEY